Additionally, several studies demonstrated that selenium compounds could sensitize tumor cells to various chemotherapies by inhibiting hypoxia-inducible factors (HIFs) expression which in turn inhibit the expression of PD-L1 and VEGF [21–25]. Here, CD274 is linked to neoplasm.